Repligen
RGEN
EPS for Repligen (RGEN)
EPS in 2023 (TTM): $2.09
According to Repligen 's latest financial reports the company's current EPS (TTM) is $2.09. In 2022 the company made an earnings per share (EPS) of $3.36 an increase over its 2021 EPS that were of $2.34.
EPS history for Repligen from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.09 | -37.8% |
| 2022 | $3.36 | 43.59% |
| 2021 | $2.34 | 105.26% |
| 2020 | $1.14 | 153.33% |
| 2019 | $0.45 | 18.42% |
| 2018 | $0.38 | -47.95% |
| 2017 | $0.73 | 108.57% |
| 2016 | $0.35 | 20.69% |
| 2015 | $0.29 | 16% |
| 2014 | $0.25 | -48.98% |
| 2013 | $0.49 | 6.52% |
| 2012 | $0.46 | -512.88% |
| 2011 | -$0.11 | -1214.13% |
| 2010 | $0.010000 | -106.25% |
| 2009 | -$0.16 | -200% |
| 2008 | $0.16 | -87.79% |
| 2007 | $1.31 | -2283.33% |
| 2006 | -$0.06000 | -300% |
| 2005 | $0.03000 | -115% |
| 2004 | -$0.20 | -25.93% |
| 2003 | -$0.27 | 80% |
| 2002 | -$0.15 | -21.05% |
| 2001 | -$0.19 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -11.00% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $15.34 | 633.97% | 🇺🇸 USA |
 General Electric GE | $8.55 | 309.09% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 89.95% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -$1.44 | -168.90% | 🇺🇸 USA |
 Novavax NVAX | -$7.19 | -444.02% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.96 | -6.22% | 🇺🇸 USA |
 Bio-Techne TECH | $1.57 | -24.88% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -62.74% | 🇺🇸 USA |
 Charles River Laboratories
CRL | $9.49 | 354.07% | 🇺🇸 USA |